Mandate

Vinge advises Active Biotech on rights offering

August 05, 2022

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million.

Vinge advises Active Biotech. Vinge’s team primarily consists of Christian Lindhé, Erik Sjöman, Astrid Isberg and Johanne Örnfeldt Svensson.

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB.
September 18, 2025

Vinge advises Workday, Inc. on its $1.1 billion acquisition of Sana Labs

Vinge, together with Orrick Herrington & Sutcliffe, has advised Workday, Inc. (NASDAQ: WDAY) (“Workday”) on its acquisition of all shares in Sana Labs AB.
September 16, 2025

Vinge advises on the sale of ArmaTech to Defensor Group

Vinge has advised on the sale of ArmaTech i Kungsbacka AB (“ArmaTech”) to the newly formed defence group Defensor Group AB (“Defensor”).
September 16, 2025